What Avalo Therapeutics (AVTX)'s Russell Index Additions and Board Refresh Mean for ShareholdersSimplywall·Jul 7 at 02:54 PMAVTX+3.83%
Avalo Therapeutics CMO Mittie Doyle disposes of 4,654 common shares valued at $93,080PUBT·Jul 2 at 03:07 PMAVTX+3.83%
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® IndexesUnusual Whales·Jun 26 at 06:01 AMAVTX+3.83%
Avalo Therapeutics CMO Mittie Doyle disposes of 1,450 common shares valued at $26,100PUBT·Jun 25 at 04:26 PMAVTX+3.83%
Avalo Therapeutics director Philip Ron M files initial beneficial ownership statementPUBT·Jun 25 at 04:24 PMAVTX+3.83%
Avalo Therapeutics appoints Ron Philip to board of directorsPUBT·Jun 23 at 06:00 AMAVTX+3.83%RHHBY+1.45%
This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga_article·Jun 12 at 06:10 AMPEP+1.25%AVTX+3.83%
Q2 EPS Forecast for Avalo Therapeutics Boosted by AnalystMarket Beat·May 19 at 06:30 AMAVTX+3.83%FBT-0.57%
Citizens Jmp Cuts Avalo Therapeutics (NASDAQ:AVTX) Price Target to $55.00Market Beat·May 14 at 09:34 AMAVTX+3.83%IBB-0.44%
These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Resultsbenzinga_article·May 14 at 08:18 AMAVTX+3.83%ARKG-2.60%
